Facebook
Twitter
Telegram
Report an ErrorPhathom Pharmaceuticals Income Statement 2011-2024 | PHAT
Annual Income Statement Phathom Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
471 M | 342 M | 728 M | 1.31 B | 397 M | - | - | - | - | - | - | - | - |
Shares |
51.3 M | 39.1 M | 37 M | 34.1 M | 11.4 M | - | - | - | - | - | - | - | - |
Historical Prices |
9.19 | 8.74 | 19.7 | 33.2 | 31.1 | - | - | - | - | - | - | - | - |
Net Income |
-202 M | -198 M | -144 M | -129 M | -255 M | -1.29 M | - | - | - | - | - | - | - |
Revenue |
682 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
167 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
515 K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-167 M | -172 M | -135 M | -126 M | -106 M | -1.22 M | - | - | - | - | - | - | - |
Interest Expense |
42 M | 27.3 M | 6.79 M | 4.58 M | 4.18 M | 13 K | - | - | - | - | - | - | - |
EBITDA |
-167 M | -172 M | -135 M | -125 M | -106 M | -1.28 M | - | - | - | - | - | - | - |
Operating Expenses |
168 M | 172 M | 135 M | 126 M | 106 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
118 M | 101 M | 62.7 M | 27.5 M | 6.94 M | 1.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Phathom Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
56.8 M | 48.5 M | 42.4 M | 41.5 M | 38.8 M | 38.3 M | 38 M | 30.5 M | 37.3 M | 36.6 M | 36.3 M | 34.1 M | 33.4 M | 33 M | 32.5 M | 24.7 M | 7.33 M | 6.69 M | 6.59 M | 6.76 M | 6.76 M | 6.76 M | 3.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-43.2 M | -41 M | -37.8 M | - | -51.1 M | -50.9 M | -40.7 M | - | -36.7 M | -36.6 M | -34.8 M | -53.7 M | -34.1 M | -21.1 M | -20.1 M | -98 M | -68.1 M | -87.8 M | -1.25 M | -484 K | -290 K | -260 K | -254 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-35.7 M | -31.7 M | -30.1 M | - | -42.5 M | -45.4 M | -37.9 M | - | -33.1 M | -35.3 M | -33.6 M | -52.4 M | -32.8 M | -20 M | -20.4 M | -15.7 M | -6.28 M | -83 M | -1.23 M | -451 K | -268 K | -255 K | -251 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
10.1 M | 9.62 M | 9.22 M | - | 9.28 M | 5.67 M | 2.76 M | - | 1.48 M | 1.26 M | 1.27 M | - | 1.29 M | 1.26 M | 738 K | - | 1.99 M | 1.14 M | 11 K | - | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-35.6 M | -31.6 M | -29.9 M | - | -42.3 M | -45.3 M | -37.8 M | - | -32.8 M | -35.2 M | -33.5 M | -52.4 M | -32.6 M | -19.9 M | -20.3 M | -15.7 M | -6.28 M | -83 M | -1.23 M | -451 K | -268 K | -255 K | -251 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
35.7 M | 31.7 M | 30.1 M | - | 42.5 M | 45.4 M | 37.9 M | - | 33.1 M | 35.3 M | 33.6 M | 52.4 M | 32.8 M | 20 M | 20.4 M | 15.7 M | 6.28 M | 83 M | 1.23 M | 451 K | 268 K | 255 K | 251 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
23.4 M | 18.9 M | 18.6 M | - | 23.5 M | 26.5 M | 20.2 M | - | 16.5 M | 13.7 M | 13 M | 10.8 M | 7.06 M | 5.16 M | 4.51 M | 2.99 M | 1.81 M | 1.34 M | 797 K | 437 K | 262 K | 255 K | 251 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency